Dr. Quay featured on Align Podcast with Aaron Alexander

The Science Behind the Past, Present, and Future of COVID.

Where did COVID come from? What can you do right now to make sure you can fight the virus, if you are ever infected? Should you get vaccinated?

In this episode of the Align Podcast, Dr. Steven Quay and Aaron Alexander discuss how the Coronavirus has been able to develop so quickly in the human body, the mechanisms of it, and how our immune system works to fight it. They talk about how exactly vaccines act to help our body fight viruses and how the antibody-dependent enhancement’s (ADE) unpredictability can affect people of different ages.

What is discussed:

03:58: How can we train our body to help combat COVID and other respiratory diseases?

06:09: Aaron’s symptoms when he was infected with COVID

08:04: What does Dr. Quay recommend you do to fight Covid?

09:20: Supportive breathing practices you can start today

10:27: Where does the virus originate from?

15:19: What kind of repercussions has Dr. Quay faced for his scientific opinions? 

17:59: What will the world be like post-vaccination?

19:06: Should young and healthy people take the vaccine?

20:35: The race between covid-2 vs the immune system

21:42: Are masks effective?

27:39: What does the future of the coronavirus look like?

30:41: The antibody-dependent enhancement (ADE)

32:28: What is the virus’ infection mechanism?

34:39: Describing the 3 phases of the virus

36:09: The burden of COVID in our world and political implications

40:56: Physiologic response to the vaccine Vs developed immune response

47:03: Why did Dr. Quay write his book?

48:50: What can we do to protect ourselves if we suspect we were exposed to the virus?

49:55: Why does it turn into pneumonia?

52:31: The issue with western medicine not looking at the importance of nutrition

57:52: How the metro transport system could have been the conduit to spreading COVID in major cities

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

(Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies

Dr. Steven Quay investigates COVID-19's origins, analyzing evidence that suggests SARS-CoV-2 may have resulted from a lab incident rather than natural transmission. Through statistical methods, Dr. Quay estimates a 98% probability of a lab origin, challenging popular theories about animal-to-human transmission and highlighting possible lab safety issues in Wuhan. In this video, he also emphasizes the importance of global safety regulations to prevent future pandemics. Watch to uncover key insights on COVID-19's origins and why lab safety matters for global health.

This video describes the clinical data from the Atossa Therapeutics press release of October 31, 2024 entitled, Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer